Pub. Date : 2011 Oct
PMID : 21903741
3 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
1 | This pilot study examines the correlation of PET using (11)C-labeled 4-N-(3-bromoanilino)-6,7-dimethoxyquinazoline ((11)C-PD153035), an imaging biomarker of epidermal growth factor receptor (EGFR), with outcomes in patients with non-small cell lung cancer (NSCLC) treated with the EGFR tyrosine kinase inhibitor erlotinib. | 4-((3-bromophenyl)amino)-6,7-dimethoxyquinazoline | epidermal growth factor receptor | Homo sapiens |
2 | This pilot study examines the correlation of PET using (11)C-labeled 4-N-(3-bromoanilino)-6,7-dimethoxyquinazoline ((11)C-PD153035), an imaging biomarker of epidermal growth factor receptor (EGFR), with outcomes in patients with non-small cell lung cancer (NSCLC) treated with the EGFR tyrosine kinase inhibitor erlotinib. | 4-((3-bromophenyl)amino)-6,7-dimethoxyquinazoline | epidermal growth factor receptor | Homo sapiens |
3 | This pilot study examines the correlation of PET using (11)C-labeled 4-N-(3-bromoanilino)-6,7-dimethoxyquinazoline ((11)C-PD153035), an imaging biomarker of epidermal growth factor receptor (EGFR), with outcomes in patients with non-small cell lung cancer (NSCLC) treated with the EGFR tyrosine kinase inhibitor erlotinib. | 4-((3-bromophenyl)amino)-6,7-dimethoxyquinazoline | epidermal growth factor receptor | Homo sapiens |